Neonatal hemolytic disease due to anti-A1 accompany fetomaternal transfusion: A case report

Author:

He Yanjing1,Wang Qiushi1ORCID

Affiliation:

1. Shengjing Hospital of China Medical University

Abstract

Abstract Background: A neonatal with severe anemia(HB:48g/L)was detected before blood transfusion. A major crossmatch-incompatible result was found with a AB donor and the further some of random 8 donors. To diagnosis the reason of anemia and the mismatched, a series serological tests were detected. Case presentation: The AB positive neonatal was born by B positive mother and AB dad. The neonatal DAT was negative, but the elution was positive with A1 cell and negative with A2 cell. In his mother serum, titer 1024 anti-A were checked out in saline tube, after treated by DTT, titer 64 anti-A1 and 2 anti-A were checked out. The neonatal was diagnosis with Hemolytic disease of the newborn (HDFN). His mother red cell showed a weak agglutinated with anti-A under microscopy. Then was diagnosis as fetomaternal hemorrhage (FMH) through the Kleihauer-Betke test and flow cytometry. A2B red blood were given combine with phototherapy, the neonatal HB was 108g/L on the day 11 before discharged. Conclusions: This is a rare case concurrent FMH and HDFN. The massive red cell of fetus entried maternal blood because of FMH, and then AB fetus red blood tiggered the high titer anti-A1 IgG and caused HDFN.

Publisher

Research Square Platform LLC

Reference24 articles.

1. Maternal IgG anti-A and anti-B titres predict outcome in ABOincompatibility in the neonate;Bakkeheim E;Acta Paediatr.,2009

2. de Haas, M., Thurik, F. F., Koelewijn, J. M. & van der Schoot, C. E. Haemolytic disease of the fetus and newborn. Vox Sang. 109, 99–113 (2015).

3. Impact of physician awareness on diagnosis of fetomaternal hemorrhage.Neonatology,2014,;Annemarie Stroustrup Callie

4. Roback JD.AABB TECHNICAL MANUAL.7th ed.USA.2011:370–371.

5. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother;Wang M;Pediatr Blood Cancer,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3